Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinopathy of Prematurity | 29 | 2023 | 408 | 4.740 |
Why?
|
Artificial Intelligence | 19 | 2023 | 1661 | 1.880 |
Why?
|
Image Processing, Computer-Assisted | 19 | 2022 | 8968 | 1.560 |
Why?
|
Information Storage and Retrieval | 8 | 2015 | 826 | 1.460 |
Why?
|
Diagnostic Imaging | 18 | 2022 | 3495 | 1.130 |
Why?
|
Brain Neoplasms | 19 | 2020 | 8776 | 1.070 |
Why?
|
Glioblastoma | 12 | 2020 | 3344 | 0.900 |
Why?
|
Natural Language Processing | 6 | 2021 | 936 | 0.900 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 5 | 2016 | 1568 | 0.870 |
Why?
|
Algorithms | 28 | 2021 | 13647 | 0.860 |
Why?
|
Glioma | 8 | 2022 | 3292 | 0.860 |
Why?
|
Diagnostic Techniques, Ophthalmological | 3 | 2018 | 254 | 0.780 |
Why?
|
Solitary Pulmonary Nodule | 3 | 2021 | 267 | 0.750 |
Why?
|
Magnetic Resonance Imaging | 36 | 2022 | 34151 | 0.720 |
Why?
|
Ophthalmoscopy | 6 | 2022 | 176 | 0.700 |
Why?
|
Radiology Information Systems | 4 | 2022 | 542 | 0.690 |
Why?
|
Software | 9 | 2020 | 4345 | 0.670 |
Why?
|
Retinal Vein | 4 | 2021 | 48 | 0.670 |
Why?
|
Image Interpretation, Computer-Assisted | 12 | 2019 | 3418 | 0.560 |
Why?
|
Ophthalmology | 4 | 2022 | 487 | 0.530 |
Why?
|
Gallbladder Neoplasms | 3 | 2011 | 159 | 0.520 |
Why?
|
Medicine | 1 | 2021 | 851 | 0.510 |
Why?
|
Radiology | 7 | 2022 | 1931 | 0.510 |
Why?
|
Retinal Vessels | 5 | 2020 | 767 | 0.490 |
Why?
|
Phenylurea Compounds | 1 | 2016 | 553 | 0.480 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2016 | 652 | 0.480 |
Why?
|
Retinal Artery | 3 | 2021 | 115 | 0.480 |
Why?
|
ROC Curve | 12 | 2022 | 3518 | 0.470 |
Why?
|
Vocabulary, Controlled | 1 | 2014 | 193 | 0.470 |
Why?
|
Telemedicine | 5 | 2022 | 2583 | 0.460 |
Why?
|
Contrast Media | 10 | 2020 | 5267 | 0.460 |
Why?
|
Fundus Oculi | 4 | 2023 | 460 | 0.460 |
Why?
|
Head and Neck Neoplasms | 6 | 2020 | 2591 | 0.450 |
Why?
|
Retina | 4 | 2022 | 2649 | 0.450 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2017 | 827 | 0.450 |
Why?
|
Severity of Illness Index | 8 | 2021 | 16008 | 0.440 |
Why?
|
Quinolines | 1 | 2016 | 737 | 0.430 |
Why?
|
Gestational Age | 13 | 2022 | 3378 | 0.430 |
Why?
|
Photography | 6 | 2021 | 535 | 0.420 |
Why?
|
Subtraction Technique | 1 | 2014 | 543 | 0.410 |
Why?
|
Infant, Newborn | 28 | 2023 | 24433 | 0.400 |
Why?
|
Reproducibility of Results | 25 | 2022 | 19423 | 0.380 |
Why?
|
Radiation Oncology | 2 | 2014 | 507 | 0.360 |
Why?
|
Radiography, Thoracic | 5 | 2022 | 1344 | 0.360 |
Why?
|
Humans | 120 | 2023 | 708843 | 0.360 |
Why?
|
Tomography, X-Ray Computed | 13 | 2022 | 20308 | 0.340 |
Why?
|
Radiotherapy, Conformal | 1 | 2011 | 563 | 0.340 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2017 | 3876 | 0.310 |
Why?
|
Database Management Systems | 1 | 2008 | 286 | 0.310 |
Why?
|
Peripheral Arterial Disease | 3 | 2022 | 1206 | 0.310 |
Why?
|
Databases, Factual | 8 | 2021 | 7763 | 0.290 |
Why?
|
Lung Neoplasms | 5 | 2021 | 12183 | 0.280 |
Why?
|
Automation | 5 | 2020 | 589 | 0.280 |
Why?
|
Sensitivity and Specificity | 12 | 2022 | 14836 | 0.270 |
Why?
|
Phantoms, Imaging | 6 | 2018 | 2401 | 0.260 |
Why?
|
Tumor Burden | 3 | 2022 | 1906 | 0.260 |
Why?
|
Delivery of Health Care | 1 | 2021 | 4810 | 0.250 |
Why?
|
Medical Informatics | 4 | 2020 | 736 | 0.240 |
Why?
|
Internet | 2 | 2014 | 3074 | 0.240 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2008 | 1829 | 0.240 |
Why?
|
Clinical Competence | 2 | 2016 | 4615 | 0.240 |
Why?
|
Stroke | 2 | 2022 | 9256 | 0.220 |
Why?
|
User-Computer Interface | 4 | 2015 | 1433 | 0.220 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 8877 | 0.220 |
Why?
|
Survival Analysis | 4 | 2016 | 10507 | 0.220 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2007 | 753 | 0.220 |
Why?
|
Reference Standards | 7 | 2021 | 992 | 0.210 |
Why?
|
Lung | 6 | 2022 | 9706 | 0.210 |
Why?
|
Retrospective Studies | 19 | 2022 | 71483 | 0.210 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 1234 | 0.200 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2015 | 440 | 0.200 |
Why?
|
Computer Communication Networks | 2 | 2020 | 286 | 0.200 |
Why?
|
Hospital Units | 1 | 2021 | 148 | 0.190 |
Why?
|
Pattern Recognition, Automated | 4 | 2020 | 1019 | 0.190 |
Why?
|
Neonatal Screening | 3 | 2022 | 554 | 0.190 |
Why?
|
Benchmarking | 4 | 2014 | 915 | 0.180 |
Why?
|
Hyperemia | 1 | 2020 | 226 | 0.180 |
Why?
|
Diverticulitis | 1 | 2021 | 162 | 0.180 |
Why?
|
Proportional Hazards Models | 4 | 2011 | 12292 | 0.180 |
Why?
|
Musculoskeletal System | 1 | 2021 | 175 | 0.180 |
Why?
|
Perfusion Imaging | 1 | 2020 | 189 | 0.180 |
Why?
|
Observer Variation | 3 | 2018 | 2687 | 0.180 |
Why?
|
Age Determination by Skeleton | 1 | 2018 | 130 | 0.170 |
Why?
|
Male | 44 | 2023 | 349524 | 0.170 |
Why?
|
Postoperative Care | 2 | 2019 | 1514 | 0.170 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2021 | 709 | 0.170 |
Why?
|
Rectal Neoplasms | 2 | 2021 | 1117 | 0.170 |
Why?
|
Documentation | 2 | 2015 | 869 | 0.170 |
Why?
|
Intestinal Obstruction | 1 | 2021 | 415 | 0.160 |
Why?
|
Radiotherapy, Intensity-Modulated | 4 | 2016 | 782 | 0.160 |
Why?
|
Statistics as Topic | 2 | 2014 | 2402 | 0.160 |
Why?
|
Dacarbazine | 3 | 2015 | 585 | 0.160 |
Why?
|
Female | 39 | 2023 | 375205 | 0.160 |
Why?
|
Radiography | 5 | 2022 | 6989 | 0.160 |
Why?
|
Medical Record Linkage | 1 | 2018 | 279 | 0.160 |
Why?
|
Cerebellar Neoplasms | 1 | 2022 | 601 | 0.150 |
Why?
|
Adrenoleukodystrophy | 1 | 2017 | 113 | 0.150 |
Why?
|
Forecasting | 3 | 2019 | 2941 | 0.150 |
Why?
|
Medulloblastoma | 1 | 2022 | 715 | 0.150 |
Why?
|
Skin Diseases, Genetic | 1 | 2016 | 39 | 0.150 |
Why?
|
Breast Neoplasms | 2 | 2020 | 19800 | 0.150 |
Why?
|
Pharyngeal Muscles | 1 | 2016 | 73 | 0.150 |
Why?
|
Area Under Curve | 4 | 2021 | 1688 | 0.150 |
Why?
|
Oxygen | 2 | 2021 | 4150 | 0.150 |
Why?
|
Microcirculation | 2 | 2017 | 1301 | 0.140 |
Why?
|
Blood Volume Determination | 1 | 2015 | 45 | 0.140 |
Why?
|
Brain | 8 | 2021 | 24969 | 0.140 |
Why?
|
Capillary Permeability | 1 | 2019 | 860 | 0.140 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2021 | 578 | 0.140 |
Why?
|
Preoperative Period | 1 | 2017 | 552 | 0.140 |
Why?
|
Physical Phenomena | 1 | 2014 | 51 | 0.140 |
Why?
|
India | 1 | 2021 | 1967 | 0.140 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2018 | 2641 | 0.140 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2018 | 641 | 0.140 |
Why?
|
Arteries | 2 | 2019 | 1131 | 0.130 |
Why?
|
Polysaccharides, Bacterial | 1 | 2017 | 589 | 0.130 |
Why?
|
National Cancer Institute (U.S.) | 3 | 2020 | 249 | 0.130 |
Why?
|
Appendicitis | 1 | 2021 | 626 | 0.130 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2018 | 403 | 0.130 |
Why?
|
Radiometry | 1 | 2020 | 823 | 0.130 |
Why?
|
Aged | 25 | 2022 | 161488 | 0.130 |
Why?
|
Aneurysm, Ruptured | 1 | 2019 | 483 | 0.130 |
Why?
|
Medical Records Systems, Computerized | 2 | 2013 | 1207 | 0.130 |
Why?
|
Blood-Brain Barrier | 2 | 2017 | 992 | 0.130 |
Why?
|
Middle Aged | 24 | 2021 | 213752 | 0.120 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2016 | 268 | 0.120 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13714 | 0.120 |
Why?
|
Computer Literacy | 1 | 2013 | 43 | 0.120 |
Why?
|
Quality Assurance, Health Care | 2 | 2014 | 2274 | 0.120 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1121 | 0.120 |
Why?
|
Prognosis | 8 | 2021 | 28919 | 0.120 |
Why?
|
Brachial Plexus | 1 | 2014 | 168 | 0.120 |
Why?
|
Gadolinium | 1 | 2017 | 910 | 0.120 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2017 | 1565 | 0.120 |
Why?
|
Low Back Pain | 1 | 2021 | 922 | 0.120 |
Why?
|
Organs at Risk | 1 | 2014 | 333 | 0.110 |
Why?
|
Cranial Irradiation | 1 | 2015 | 435 | 0.110 |
Why?
|
Bayes Theorem | 2 | 2016 | 1994 | 0.110 |
Why?
|
Otorhinolaryngologic Neoplasms | 1 | 2011 | 26 | 0.110 |
Why?
|
Brain Diseases | 1 | 2021 | 1530 | 0.110 |
Why?
|
Blood Vessels | 1 | 2017 | 1165 | 0.110 |
Why?
|
SEER Program | 3 | 2011 | 1549 | 0.110 |
Why?
|
Infant, Premature | 5 | 2018 | 1989 | 0.100 |
Why?
|
Vascular Malformations | 1 | 2016 | 424 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2023 | 3490 | 0.100 |
Why?
|
Fibrosis | 1 | 2017 | 1947 | 0.100 |
Why?
|
Deglutition Disorders | 1 | 2016 | 566 | 0.100 |
Why?
|
Arteriovenous Malformations | 1 | 2013 | 380 | 0.100 |
Why?
|
Biomedical Research | 2 | 2019 | 3266 | 0.100 |
Why?
|
Linear Models | 1 | 2021 | 5986 | 0.100 |
Why?
|
Computer-Assisted Instruction | 1 | 2014 | 379 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 3 | 2015 | 3984 | 0.100 |
Why?
|
Nomograms | 1 | 2011 | 225 | 0.100 |
Why?
|
Neovascularization, Pathologic | 2 | 2019 | 2715 | 0.090 |
Why?
|
Optic Disk | 1 | 2013 | 389 | 0.090 |
Why?
|
Intracranial Aneurysm | 1 | 2019 | 1342 | 0.090 |
Why?
|
Joint Instability | 1 | 2016 | 748 | 0.090 |
Why?
|
Mammography | 1 | 2020 | 2442 | 0.090 |
Why?
|
Oregon | 1 | 2008 | 138 | 0.090 |
Why?
|
Colonic Neoplasms | 1 | 2021 | 2535 | 0.090 |
Why?
|
Administration, Oral | 1 | 2016 | 3944 | 0.090 |
Why?
|
Patient Readmission | 1 | 2022 | 2952 | 0.090 |
Why?
|
Endovascular Procedures | 1 | 2022 | 1959 | 0.090 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15252 | 0.090 |
Why?
|
Radiation Injuries | 1 | 2016 | 1228 | 0.080 |
Why?
|
MEDLINE | 1 | 2008 | 127 | 0.080 |
Why?
|
Prostatic Neoplasms | 3 | 2020 | 10525 | 0.080 |
Why?
|
Adult | 19 | 2022 | 211041 | 0.080 |
Why?
|
Liver Cirrhosis | 1 | 2017 | 1721 | 0.080 |
Why?
|
Models, Statistical | 3 | 2017 | 5034 | 0.080 |
Why?
|
Total Quality Management | 1 | 2008 | 273 | 0.080 |
Why?
|
North America | 2 | 2021 | 1174 | 0.080 |
Why?
|
Angiogenesis Inhibitors | 2 | 2016 | 2067 | 0.080 |
Why?
|
Cohort Studies | 5 | 2022 | 39292 | 0.080 |
Why?
|
Tumor Microenvironment | 1 | 2018 | 2987 | 0.080 |
Why?
|
Workload | 1 | 2013 | 852 | 0.080 |
Why?
|
Neoplasms | 5 | 2020 | 20172 | 0.080 |
Why?
|
Terminology as Topic | 1 | 2014 | 1620 | 0.070 |
Why?
|
Dilatation, Pathologic | 2 | 2018 | 517 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2019 | 13536 | 0.070 |
Why?
|
Diagnosis, Differential | 3 | 2019 | 13274 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11253 | 0.070 |
Why?
|
Infant | 7 | 2023 | 34261 | 0.070 |
Why?
|
Feasibility Studies | 2 | 2014 | 4883 | 0.070 |
Why?
|
Models, Biological | 3 | 2019 | 9907 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 4969 | 0.070 |
Why?
|
Exercise | 1 | 2020 | 5251 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2022 | 61932 | 0.060 |
Why?
|
Prospective Studies | 6 | 2022 | 50597 | 0.060 |
Why?
|
Birth Weight | 2 | 2021 | 1893 | 0.060 |
Why?
|
Young Adult | 7 | 2018 | 55940 | 0.060 |
Why?
|
Computer Simulation | 4 | 2017 | 6048 | 0.060 |
Why?
|
Survival Rate | 3 | 2018 | 13202 | 0.060 |
Why?
|
X-Rays | 1 | 2022 | 293 | 0.060 |
Why?
|
Mass Screening | 1 | 2018 | 5182 | 0.060 |
Why?
|
Liver | 1 | 2017 | 7622 | 0.050 |
Why?
|
Risk Factors | 6 | 2022 | 69553 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7428 | 0.050 |
Why?
|
Research Design | 2 | 2014 | 5833 | 0.050 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2018 | 720 | 0.050 |
Why?
|
Monte Carlo Method | 2 | 2017 | 1301 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2018 | 58184 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2019 | 1470 | 0.050 |
Why?
|
Periodicals as Topic | 1 | 2012 | 1403 | 0.050 |
Why?
|
Cluster Analysis | 1 | 2007 | 2750 | 0.050 |
Why?
|
Child | 7 | 2022 | 73636 | 0.050 |
Why?
|
Positron-Emission Tomography | 4 | 2021 | 6170 | 0.050 |
Why?
|
Nepal | 1 | 2021 | 274 | 0.050 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2019 | 62 | 0.050 |
Why?
|
Utilization Review | 1 | 2021 | 400 | 0.050 |
Why?
|
Breast | 2 | 2019 | 1782 | 0.050 |
Why?
|
Limb Salvage | 1 | 2022 | 446 | 0.050 |
Why?
|
Receptors, GABA | 1 | 2021 | 261 | 0.050 |
Why?
|
Hand Bones | 1 | 2018 | 14 | 0.050 |
Why?
|
Kinetics | 2 | 2019 | 6796 | 0.050 |
Why?
|
Ecosystem | 1 | 2022 | 413 | 0.040 |
Why?
|
Hemizygote | 1 | 2017 | 30 | 0.040 |
Why?
|
Critical Illness | 2 | 2021 | 2496 | 0.040 |
Why?
|
Edema | 1 | 2022 | 744 | 0.040 |
Why?
|
Carbon Tetrachloride | 1 | 2017 | 70 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2015 | 4173 | 0.040 |
Why?
|
Ankle | 1 | 2020 | 274 | 0.040 |
Why?
|
Health Services | 1 | 2022 | 732 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 5405 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2021 | 580 | 0.040 |
Why?
|
Amputation | 1 | 2022 | 791 | 0.040 |
Why?
|
Half-Life | 1 | 2017 | 683 | 0.040 |
Why?
|
Quinazolines | 2 | 2013 | 1420 | 0.040 |
Why?
|
Expert Systems | 1 | 2016 | 85 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2021 | 1192 | 0.040 |
Why?
|
Quality Control | 1 | 2019 | 872 | 0.040 |
Why?
|
Mutation | 2 | 2017 | 29262 | 0.040 |
Why?
|
Diffusion | 1 | 2017 | 828 | 0.040 |
Why?
|
Palate, Soft | 1 | 2016 | 101 | 0.040 |
Why?
|
Antineoplastic Protocols | 1 | 2015 | 51 | 0.040 |
Why?
|
Permeability | 1 | 2017 | 791 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 2020 | 833 | 0.040 |
Why?
|
Internationality | 1 | 2021 | 1002 | 0.030 |
Why?
|
Abdomen | 1 | 2021 | 1094 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4292 | 0.030 |
Why?
|
United States | 4 | 2020 | 67165 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 577 | 0.030 |
Why?
|
Arthroscopy | 1 | 2021 | 824 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2019 | 796 | 0.030 |
Why?
|
Models, Theoretical | 2 | 2021 | 3558 | 0.030 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2016 | 919 | 0.030 |
Why?
|
Lower Extremity | 1 | 2022 | 1041 | 0.030 |
Why?
|
Risk Assessment | 2 | 2022 | 23284 | 0.030 |
Why?
|
Skull | 1 | 2018 | 816 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1349 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 2016 | 1746 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2017 | 2428 | 0.030 |
Why?
|
DNA Modification Methylases | 1 | 2013 | 209 | 0.030 |
Why?
|
Platelet Count | 1 | 2015 | 794 | 0.030 |
Why?
|
Perfusion | 1 | 2016 | 1272 | 0.030 |
Why?
|
Reference Values | 1 | 2020 | 5041 | 0.030 |
Why?
|
Thoracic Neoplasms | 1 | 2014 | 259 | 0.030 |
Why?
|
Argentina | 1 | 2013 | 222 | 0.030 |
Why?
|
Logistic Models | 2 | 2021 | 13468 | 0.030 |
Why?
|
Motion | 1 | 2015 | 751 | 0.030 |
Why?
|
Video Recording | 1 | 2017 | 949 | 0.030 |
Why?
|
DNA Repair Enzymes | 1 | 2013 | 360 | 0.030 |
Why?
|
Consensus | 1 | 2020 | 2713 | 0.030 |
Why?
|
Life Tables | 1 | 2011 | 380 | 0.030 |
Why?
|
Diabetic Retinopathy | 1 | 2020 | 1202 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2017 | 1481 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2019 | 21194 | 0.020 |
Why?
|
Information Dissemination | 1 | 2019 | 1089 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13298 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2421 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2244 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2015 | 777 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3515 | 0.020 |
Why?
|
Prostate | 1 | 2017 | 1564 | 0.020 |
Why?
|
Medical Oncology | 1 | 2021 | 2098 | 0.020 |
Why?
|
Fluorescein Angiography | 1 | 2013 | 894 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 8024 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2016 | 2927 | 0.020 |
Why?
|
Papillomaviridae | 1 | 2015 | 1124 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9641 | 0.020 |
Why?
|
Incidence | 2 | 2020 | 20320 | 0.020 |
Why?
|
Societies, Medical | 1 | 2021 | 3776 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2016 | 853 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2021 | 3851 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8712 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39038 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3418 | 0.020 |
Why?
|
PubMed | 1 | 2008 | 118 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2945 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2017 | 2748 | 0.020 |
Why?
|
Hemodynamics | 1 | 2016 | 4211 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3968 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2013 | 1632 | 0.020 |
Why?
|
Probability | 1 | 2011 | 2474 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 7026 | 0.020 |
Why?
|
Educational Status | 1 | 2013 | 2278 | 0.020 |
Why?
|
Child, Preschool | 2 | 2018 | 41081 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 2169 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10339 | 0.020 |
Why?
|
Carcinoma | 1 | 2016 | 2307 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9488 | 0.020 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1470 | 0.020 |
Why?
|
Image Enhancement | 1 | 2015 | 2975 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2878 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6293 | 0.020 |
Why?
|
Adolescent | 3 | 2018 | 84718 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2011 | 2951 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2895 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 7994 | 0.010 |
Why?
|
Smoking | 1 | 2019 | 8612 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 7089 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5348 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 9644 | 0.010 |
Why?
|
Rats | 1 | 2017 | 25094 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2017 | 5135 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6765 | 0.010 |
Why?
|
Hypertension | 1 | 2019 | 8161 | 0.010 |
Why?
|
Time Factors | 1 | 2022 | 41038 | 0.010 |
Why?
|
Ultrasonography | 1 | 2012 | 5918 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3885 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18375 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2011 | 11126 | 0.010 |
Why?
|
Internship and Residency | 1 | 2014 | 5556 | 0.010 |
Why?
|
Age Factors | 1 | 2011 | 18712 | 0.010 |
Why?
|
Mice | 1 | 2017 | 80876 | 0.010 |
Why?
|
Animals | 1 | 2017 | 170486 | 0.000 |
Why?
|